Interesting find aburbe, the editor in-chief of that journal (MOLECULES) is the Technical Director of AMYRIS, one of the fastest growing biotechs on the NASDAQ and a darling of the GATES FOUNDATION. AMYRIS and SANOFI are engaged by the Bill and Melinda Gates Foundation for producing affordable artemisinin for their malaria eradication program.....Those guys publish top research, very encouraging to see BTX1503 mentioned and reassuring to know that the company engages top scientific advisers.
BOT price action, page-329
-
- There are more pages in this discussion • 1,395 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
37.0¢ |
Change
0.015(4.23%) |
Mkt cap ! $669.7M | |||
| Open | High | Low | Value | Volume |
| 36.0¢ | 37.5¢ | 35.5¢ | $1.465M | 4.001M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 186321 | 36.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 37.5¢ | 561591 | 7 |
View Market Depth
| Last trade - 16.10pm 14/08/2024 (20 minute delay) ? |
| BOT (ASX) Chart |